306 related articles for article (PubMed ID: 14504)
1. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
Kralberg BE; Tolagen K
Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504
[TBL] [Abstract][Full Text] [Related]
2. Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.
Karlberg BE; Kågedal B; Tegler L; Tolagen K; Bergman B
Am J Cardiol; 1976 Mar; 37(4):642-9. PubMed ID: 769527
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
Bravo EL; Tarazi RC; Dustan HP
N Engl J Med; 1975 Jan; 292(2):66-70. PubMed ID: 234005
[TBL] [Abstract][Full Text] [Related]
4. Diuretics, beta-blockers or both as treatment for essential hypertension.
Stumpe KO; Overlack O
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
[TBL] [Abstract][Full Text] [Related]
5. Propranolol in the control of blood pressure: a dose-response study.
Serlin MJ; Orme ML; Baber NS; Sibeon RG; Laws E; Breckenridge A
Clin Pharmacol Ther; 1980 May; 27(5):586-92. PubMed ID: 6102895
[TBL] [Abstract][Full Text] [Related]
6. [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].
Weidmann P; Beretta-Piccoli C; Ziegler W; Hirsch D; de Châtel RD; Reubi FC
Klin Wochenschr; 1976 Aug; 54(16):765-73. PubMed ID: 8663
[TBL] [Abstract][Full Text] [Related]
7. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.
Leonetti G; Mayer G; Morganti A; Terzoli L; Zanchetti A; Bianchetti G; Di Salle E; Morselli PL; Chidsey CA
Clin Sci Mol Med Suppl; 1975 Jun; 48(6):491-9. PubMed ID: 1056279
[TBL] [Abstract][Full Text] [Related]
8. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
Hollifield JW; Sherman K; Zwagg RV; Shand DG
N Engl J Med; 1976 Jul; 295(2):68-73. PubMed ID: 775330
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
10. Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.
Karlberg BE; Kågedal B; Tegler L; Tolagen K
Br Med J; 1976 Jan; 1(6004):251-4. PubMed ID: 764929
[TBL] [Abstract][Full Text] [Related]
11. Time course of development of the antihypertensive effect of propranolol.
Fagan TC; Walle T; Corns-Hurwitz R; Conradi EC; Privitera P; Harmon G; Degenhart W; Gaffney TE
Hypertension; 1983; 5(6):852-7. PubMed ID: 6360868
[TBL] [Abstract][Full Text] [Related]
12. Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
Matsunaga M; Hara A; Ogino K; Motohara S; Saito M
Jpn Heart J; 1977 Jan; 18(1):24-30. PubMed ID: 15142
[TBL] [Abstract][Full Text] [Related]
13. Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol.
Laragh JH
Am J Med; 1976 Nov; 61(5):797-810. PubMed ID: 10730
[TBL] [Abstract][Full Text] [Related]
14. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
Zweifler A; Esler M
Am J Cardiol; 1977 Jul; 40(1):105-9. PubMed ID: 879001
[TBL] [Abstract][Full Text] [Related]
16. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
Jackson B; Morgan TO; Gibson J; Anderson A
Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
[TBL] [Abstract][Full Text] [Related]
17. Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients.
Mitchell HC; Pettinger WA
Clin Pharmacol Ther; 1981 Sep; 30(3):297-302. PubMed ID: 6115731
[TBL] [Abstract][Full Text] [Related]
18. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.
Stumpe KO; Kolloch R; Vetter H; Gramann W; Krück F; Ressel C; Higuchi M
Am J Med; 1976 May; 60(6):853-65. PubMed ID: 14499
[TBL] [Abstract][Full Text] [Related]
19. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
20. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
Drayer JI; Kloppenborg PW; Festen J; van't Laar A; Benraad TJ
Am J Cardiol; 1975 Oct; 36(5):716-21. PubMed ID: 1103606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
